FIELD: medicine.
SUBSTANCE: preparation comprises echinocandine substance of formula I 
or its pharmaceutically permissible salt, pharmaceutically permissible micelle-forming surface-active agent and non-toxic aqueous solvent and stabilizing agent.
EFFECT: improved stability and bioaccessibility properties.
48 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS | 2013 |
|
RU2719579C2 |
| DOSING MODES FOR ECHINOCANDINE CLASS COMPOUNDS | 2013 |
|
RU2639483C2 |
| DRUG DELIVERY SYSTEMS BASED ON MAYTANSINOID | 2018 |
|
RU2783076C2 |
| COMPOSITION AND METHOD FOR PRODUCTION OF ENHANCED STABILITY MEDICATIONS SLIGHTLY SOLUBLE IN WATER | 2006 |
|
RU2451510C2 |
| EPOTHILONE-CONTAINING COMPOSITIONS | 1999 |
|
RU2214246C2 |
| ALBUMIN-BINDING PRODRUGS BASED ON AURISTATIN E DERIVATIVES | 2018 |
|
RU2795101C2 |
| DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE | 2016 |
|
RU2748992C2 |
| LYOPHILIZED COMPOSITION | 1999 |
|
RU2268045C2 |
| NEW POTENTIAL ANTIFUNGAL AGENTS BASED ON THIAZOLIDINE-2,4-DIONE AND TRIAZOLE | 2023 |
|
RU2814730C1 |
| PROTEIN STABILISATION FORMULATION FREE FROM MAMMALIAN EXCIPIENTS | 2010 |
|
RU2539388C2 |
